We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXT icon
2076
Rackspace Technology
RXT
$1.21B
$17.2M ﹤0.01%
875,780
+166,601
+23% +$3.69M
TCMD icon
2077
Tactile Systems Technology
TCMD
$672M
$17.2M ﹤0.01%
330,073
+14,219
+5% +$769K
DMTK
2078
DELISTED
DermTech, Inc. Common Stock
DMTK
$17.1M ﹤0.01%
411,554
+116,429
+39% +$4.78M
ATEC icon
2079
Alphatec Holdings
ATEC
$1.56B
$17.1M ﹤0.01%
1,113,198
+167,436
+18% +$2.58M
CCCC icon
2080
C4 Therapeutics
CCCC
$387M
$17M ﹤0.01%
450,542
+257,950
+134% +$9.24M
CAL icon
2081
Caleres
CAL
$470M
$17M ﹤0.01%
624,121
+16,331
+3% +$409K
ROAD icon
2082
Construction Partners
ROAD
$6.11B
$17M ﹤0.01%
542,372
+26,266
+5% +$825K
PPC icon
2083
Pilgrim's Pride
PPC
$6.65B
$17M ﹤0.01%
767,718
-19,251
-2% -$458K
OSH
2084
DELISTED
Oak Street Health, Inc.
OSH
$17M ﹤0.01%
292,287
+36,973
+14% +$2.2M
GRPN icon
2085
Groupon
GRPN
$1.05B
$17M ﹤0.01%
394,125
+7,317
+2% +$344K
AHRT
2086
AH Realty Trust
AHRT
$527M
$17M ﹤0.01%
1,278,104
+100,782
+9% +$1.35M
LSPD icon
2087
Lightspeed Commerce
LSPD
$1.33B
$17M ﹤0.01%
204,584
+180,145
+737% +$12.7M
BHE icon
2088
Benchmark Electronics
BHE
$2.91B
$16.9M ﹤0.01%
594,154
+19,051
+3% +$574K
MYE icon
2089
Myers Industries
MYE
$1.38B
$16.9M ﹤0.01%
804,916
+8,383
+1% +$179K
PRTY
2090
DELISTED
Party City Holdco Inc.
PRTY
$16.9M ﹤0.01%
1,810,977
+892,273
+97% +$7.28M
PRSU
2091
Pursuit Attractions and Hospitality Inc
PRSU
$1.41B
$16.9M ﹤0.01%
338,741
+5,353
+2% +$237K
VTLE
2092
DELISTED
Vital Energy
VTLE
$16.8M ﹤0.01%
181,396
+108,255
+148% +$5.58M
AMTI
2093
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$16.8M ﹤0.01%
367,439
+47,534
+15% +$2.25M
CCJ icon
2094
Cameco
CCJ
$39.1B
$16.8M ﹤0.01%
883,438
+80,107
+10% +$1.51M
DBD
2095
DELISTED
Diebold Nixdorf Incorporated
DBD
$16.8M ﹤0.01%
1,307,361
+44,813
+4% +$615K
TBI
2096
Trueblue
TBI
$229M
$16.7M ﹤0.01%
593,361
+19,955
+3% +$531K
ERII icon
2097
Energy Recovery
ERII
$459M
$16.6M ﹤0.01%
730,253
+34,344
+5% +$677K
NX icon
2098
Quanex
NX
$883M
$16.6M ﹤0.01%
668,000
+17,575
+3% +$469K
QADA
2099
DELISTED
QAD Inc.
QADA
$16.6M ﹤0.01%
190,623
+5,560
+3% +$406K
KYMR icon
2100
Kymera Therapeutics
KYMR
$8.25B
$16.6M ﹤0.01%
341,542
+154,884
+83% +$6.72M

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.